… ProQR to Present at the Evercore ISI HealthConX Conference … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …
… ProQR Announces Participation in Upcoming Kempen Life … & CAMBRIDGE, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a … 2021 Thematic Virtual Series on April 28, 2021. About ProQRProQR Therapeutics is dedicated to changing lives …
… ProQR to Present at Two Investor Conferences in October … Mass., Sept. 30, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … will be held from October 2-4, 2019 in New York, NY. ProQR will present on Wednesday, October 2, 2019 at 3:35 pm …
… ProQR Announces Results for the Third Quarter of 2016 LEIDEN, the Netherlands, Nov. 14, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … said Daniel de Boer, Chief Executive Officer of ProQR “I’m proud of the team that has designed and executed …
… ProQR to Present at Three Scientific Conferences in April … and CAMBRIDGE, Mass., April 22, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … K. Koenekoop, MD, PhD, principle investigator of the ProQR Phase 1/2 STELLAR clinical trial of QR-421a and …
… ProQR to Present at the JMP Life Sciences Conference LEIDEN, the Netherlands, June 14, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … am ET, Gerard Platenburg, Chief Innovation Officer of ProQR, will participate in an analyst led fireside chat …
… ProQR to Present at the Chardan Genetic Medicines Conference … LEIDEN, the Netherlands, Oct. 02, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … Presenter : Gerard Platenburg, chief innovation officer of ProQR Presentation : Tuesday, October 9, 2018 at 8:00 am ET …
… ProQR Prices $90 Million Underwritten Public Offering of … and CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated … of $6.50 per share. All of the shares are being offered by ProQR. In addition, ProQR has granted the underwriters a …
… ProQR Prices $90.6 Million Underwritten Public Offering of … and CAMBRIDGE, Mass., Sept. 07, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a biopharmaceutical … share. All of the shares are being offered by ProQR. The offering is expected to close on September 11, …